Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07423377 · ClinicalTrials.gov registry record · NA
Vestibular Innovation in Pain 2
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT07423377 is a NA study that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 56 participants.
The verdict
NCT07423377, a NA study, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
Fibromyalgia is the most common centralized pain disorder, affecting up to 3% of the population. Current treatments are incompletely effective, often poorly tolerated, and costly: there remains an urgent need for novel, effective, and well-tolerated therapy. Preliminary data suggests that vestibulocortical stimulation (VCS), or irrigating the external ear canal with temperate water, could rapidly improve pain and quality of life in this cohort. The VIPR trial will assess the efficacy of a single session of VCS - a safe \& cost-effective bedside technique using a plastic syringe and temperate water - relative to sham in treating pain \& improving quality of life using validated patient-reported outcomes.
Interventions
- PROCEDURE Vestibulocortical Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2026-03-19 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07423377
The ClinicalTrials.gov registry entry for NCT07423377 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vestibulocortical Stimulation is the first listed.
NCT07423377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07423377 about?
NCT07423377 is a clinical study titled "Vestibular Innovation in Pain 2". Fibromyalgia is the most common centralized pain disorder, affecting up to 3% of the population. Current treatments are incompletely effective, often poorly tolerated, and costly: there remains an urgent need for novel, effective, and well-tolerated therapy. Preliminary data suggests that vestibuloc...
What is the current status of trial NCT07423377?
This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2026-03-19. Estimated completion is 2027-07-31.
What interventions are being tested in trial NCT07423377?
The interventions under investigation include: Vestibulocortical Stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT07423377?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.